Cell cycle inhibition therapy that targets stathmin in in vitro and in vivo models of breast cancer.
about
The Fanconi Anemia C Protein Binds to and Regulates Stathmin-1 PhosphorylationStathmin-dependent molecular targeting therapy for malignant tumor: the latest 5 years' discoveries and developmentsStathmin overexpression is associated with growth, invasion and metastasis of lung adenocarcinomaFOXM1 mediates resistance to docetaxel in gastric cancer via up-regulating Stathmin.Mammary glands exhibit molecular laterality and undergo left-right asymmetric ductal epithelial growth in MMTV-cNeu mice.The prognostic value and therapeutic target role of stathmin-1 in urinary bladder cancerNovel indolyl-chalcones target stathmin to induce cancer cell death.A delay prior to mitotic entry triggers caspase 8-dependent cell death in p53-deficient Hela and HCT-116 cells.The cytotoxic effect of memantine and its effect on cytoskeletal proteins expression in metastatic breast cancer cell line.Predictive value of stathmin-1 and osteopontin expression for taxan resistance in metastatic castrate-resistant prostate cancer.Silencing Op18/stathmin by RNA Interference Promotes the Sensitivity of Nasopharyngeal Carcinoma Cells to Taxol and High-Grade Differentiation of Xenografted Tumours in Nude Mice.Rh2E2, a novel metabolic suppressor, specifically inhibits energy-based metabolism of tumor cells.Stathmin 1 expression predicts prognosis and benefits from adjuvant chemotherapy in patients with gallbladder carcinoma.miR-34a Regulates Expression of the Stathmin-1 Oncoprotein and Prostate Cancer Progression.
P2860
Q27312678-15044B39-7508-4DDF-BE77-EFEAA58F338BQ28079927-FA7F08D7-DA4A-47FF-A1A3-94576164A945Q33688496-178C5752-3B0F-4782-8862-79F71AF85702Q33991617-839B47B0-4E5F-4BA6-ACD6-101C64AADFF8Q34664059-0AF63078-DE09-4922-B690-E8AEAE59B0DAQ35214846-FE68C0AB-4499-4975-A1F0-C5ED90A371B5Q35961195-8173EAB6-F3CA-4CA1-922F-7A30B6E0D398Q36180709-CCC8E2EC-571F-4DCE-9397-C60086D69A7FQ37592867-532039EB-272F-42B5-99FA-01D032FDC8ABQ38622891-A41C2906-5B7C-442A-AB07-779AA22634D8Q38764993-F23C9E0B-FA9D-43BD-895B-AEAEEF5CE9D5Q38800502-2DD3EAE6-2AF0-49B2-AAC5-3D78D1888B19Q47172693-0317EE31-B043-452E-9FC6-9924405AA5E6Q47660322-B5F982E5-F85C-4EF6-876B-220BAE1076AB
P2860
Cell cycle inhibition therapy that targets stathmin in in vitro and in vivo models of breast cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Cell cycle inhibition therapy ...... vivo models of breast cancer.
@en
Cell cycle inhibition therapy ...... vivo models of breast cancer.
@nl
type
label
Cell cycle inhibition therapy ...... vivo models of breast cancer.
@en
Cell cycle inhibition therapy ...... vivo models of breast cancer.
@nl
prefLabel
Cell cycle inhibition therapy ...... vivo models of breast cancer.
@en
Cell cycle inhibition therapy ...... vivo models of breast cancer.
@nl
P2093
P2860
P356
P1433
P1476
Cell cycle inhibition therapy ...... vivo models of breast cancer.
@en
P2093
P2860
P2888
P304
P356
10.1038/CGT.2013.21
P577
2013-04-26T00:00:00Z